Open AccessS0645 Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
Author(s) -
William J. Sandborn,
Paul Rutgeerts,
John P. Lynch,
Rory Rebuck,
Yuhua Wang,
Bin Zou,
Christopher Gasink,
Omoniyi J. Adedokun,
Bruce E. Sands,
Stephen B. Hanauer,
Stephan R. Targan,
Subrata Ghosh,
Willem J.S. de Villiers,
Jean–Frédéric Colombel,
Brian G. Feagan
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704628.43493.6d
Subject(s) - medicine , ustekinumab , randomized controlled trial , regimen , randomization , placebo , maintenance therapy , clinical trial , surgery , gastroenterology , disease , chemotherapy , adalimumab , alternative medicine , pathology